Stay updated on Omalizumab in CRSwNP: Extension Study Clinical Trial

Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Omalizumab in CRSwNP: Extension Study Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page’s site revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T03:11:31.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The completed Phase 3 study record for Hoffmann-La Roche’s omalizumab extension trial is displayed, with details on eligibility, study design and outcomes, and 79 study locations.
    Difference
    92%
    Check dated 2026-11-11T02:08:10.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:40:56.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes appears above the existing 403 error page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:43:28.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:59:23.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study page is currently presenting a 403 Forbidden error page instead of the study details, with a simple Home link displayed on the error screen.
    Difference
    19%
    Check dated 2026-09-23T00:45:37.000Z thumbnail image

Stay in the know with updates to Omalizumab in CRSwNP: Extension Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.